Also, aberrant alternative splicing of MDM2 transcripts were found to associate with a prognostic factor for poor survival in patients with breast cancer [93], whereas HDMX has been linked to soft-tissue sarcoma [94]. Here, MDM2 is linked to breast carcinoma.